We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CNH:NYSECNH Industrial N.V. Analysis

Data as of 2026-03-14 - not real-time

$10.65

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

CNH Industrial is trading at $10.65, well below its DCF fair value of $119.7 and the analyst consensus target of $13.5, indicating a substantial valuation gap. The stock sits under the 20‑day SMA (12.01) and 50‑day SMA (11.37), but the 200‑day SMA (11.37) is nearly flat, suggesting a potential reversal zone. Momentum indicators show an RSI of 30.5, flagging oversold conditions, while the MACD histogram is negative, pointing to short‑term bearish pressure. Recent earnings beat expectations, with Q4 EPS of $0.19 versus $0.11 consensus, and revenue growth of 5.8% YoY, reinforcing the earnings momentum. The company posted a 21% YoY increase in adjusted EBIT and a free cash flow generation of $9.96 bn, supporting its dividend yield of 2.35% and a payout ratio of ~61%. However, the balance sheet is leveraged, with a debt‑to‑equity of 346% and total debt exceeding $27 bn, which could constrain future cash allocation. The sector’s beta of 1.14 and 30‑day volatility of 36.8% signal heightened price swings, while the Fear‑Greed Index at 72.9 reflects a market bias toward risk‑taking. CNH’s inclusion in the top 1% of S&P Global’s 2026 Sustainability Yearbook highlights strong ESG credentials that may attract institutional capital. Geographic exposure across North America, Europe, and emerging markets adds both growth opportunities and geopolitical risk. Overall, the combination of deep valuation discount, solid cash generation, and recent earnings beat creates a compelling upside narrative, but the high leverage and cyclical industry dynamics temper enthusiasm.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Oversold RSI indicating near‑term price bounce
  • Recent earnings beat and strong cash flow
  • Valuation discount relative to DCF and analyst targets

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustained revenue growth and margin expansion
  • Improving ESG profile attracting long‑term investors
  • Upside potential from market share gains in emerging regions

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Fundamental valuation gap remains sizable
  • Dividend yield provides income cushion
  • High leverage and cyclical exposure may limit upside

Key Metrics & Analysis

Financial Health

Revenue Growth5.80%
Profit Margin2.82%
P/E Ratio26.0
ROE6.48%
ROA1.06%
Debt/Equity346.16
P/B Ratio1.7
Op. Cash Flow$2.5B
Free Cash Flow$10.0B
Industry P/E29.1

Technical Analysis

TrendBullish
RSI30.5
Support$10.44
Resistance$13.31
MA 20$12.01
MA 50$11.37
MA 200$11.37
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair Value$119.71
Target Price$13.99
Upside/Downside31.36%
GradeUndervalued
TypeBlend
Dividend Yield2.35%

Risk Assessment

Beta1.14
Volatility36.79%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.